Meet ChromaGenixTM
Our affinity chromatography technologies enable the next generation of advanced therapies.
ChromaGenix develops novel affinity ligands and purification resins to help biopharma manufacturers purify complex biologics more efficiently, with improved yields.
Focused specifically on complex modalities, our innovative ligand development pipeline ensures robust solutions to emerging challenges in downstream purification.
DNA & mRNA
Viral Vectors
Exosomes
Lipid Nanoparticles
Resin Products
Publications
Design and Evaluation of Peptide Ligands for AAV Purification

Peptide Ligands for Purification of AAV from HEK293 Cell Lysates

Removal of host cell proteins from cell culture fluids by weak partitioning chromatography using peptide-based adsorbents

